Skip to Main Content

Course Objectives

Angiogenesis, Exudation, and Degeneration 2020

Course Objectives

Upon completion of this course, participants should be able to:

  • Examine new evidence regarding the current global use of anti-VEGF drugs for exudative ocular diseases
  • Evaluate risks associated with injections of anti-VEGF drugs
  • Analyze the rationale for emerging treatments for different macular and retinal degenerative conditions
  • Analyze results of clinical trials in exudative and non-exudative macular diseases and apply to clinical practice
  • Evaluate the benefits and limitations of combination therapies for macular diseases
  • Evaluate the benefits and limitations of different imaging strategies for macular diseases
  • Provide patients with information on the genetic nature and genetic transmission for the disease and its implication for other family members
  • Use OCT to diagnose and manage macular and retinal diseases
  • Evaluate the emerging imaging technology known as OCT angiography and how this technology might improve the diagnosis of macular and retinal diseases, as well as the clinical management of patients with these diseases